GelStat Corp. (OTCMKTS:GSAC – Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 30th, there was short interest totaling 323,333 shares, a growth of 9,274.7% from the October 15th total of 3,449 shares. Based on an average trading volume of 9,993,765 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are sold short.
GelStat Stock Performance
Shares of GSAC opened at $0.00 on Thursday. GelStat has a one year low of $0.00 and a one year high of $0.00.
GelStat Company Profile
GelStat Corporation is a specialty healthcare company associated with the development and marketing of over-the-counter products intended to address common health conditions. The company is best known for GelStat Migraine, a nonprescription product marketed for the temporary relief of migraine-related symptoms. Historically, GelStat’s product portfolio also included other consumer healthcare offerings, including products positioned for sleep support and relief from cold-related symptoms. The company’s approach focused on proprietary formulations and alternative delivery methods designed for direct consumer use rather than prescription-based treatment.
See Also
- Five stocks we like better than GelStat
- Palantir’s Real Washington Risk Isn’t the Budget—It’s Oversight
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
Receive News & Ratings for GelStat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GelStat and related companies with MarketBeat.com's FREE daily email newsletter.
